Cargando…
Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass
BACKGROUNDS: On the basis of Custodiol preservation and cardioplegic solution a novel cardioplegic solution was developed to improve the postischemic cardiac and endothelial function. In this study, we investigated whether its reduced cytotoxicity and its ability to reduce reactive oxygen species ge...
Autores principales: | Veres, Gábor, Radovits, Tamás, Merkely, Béla, Karck, Matthias, Szabó, Gábor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350983/ https://www.ncbi.nlm.nih.gov/pubmed/25890005 http://dx.doi.org/10.1186/s13019-015-0226-9 |
Ejemplares similares
-
Tiprotec preserves endothelial function after cold ischemia and warm reperfusion: comparison between Saline, Custodiol and Tiprotec
por: Gábor, Veres, et al.
Publicado: (2015) -
Effects of inosine on reperfusion injury after cardiopulmonary bypass
por: Veres, Gábor, et al.
Publicado: (2010) -
Custodiol - N versus Custodiol: a prospective randomized double blind multicenter phase III Trial
por: Szabó, Gábor, et al.
Publicado: (2015) -
Endothelial Dysfunction of Bypass Graft: Direct Comparison of In Vitro and In Vivo Models of Ischemia-Reperfusion Injury
por: Veres, Gábor, et al.
Publicado: (2015) -
Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
por: Radovits, Tamás, et al.
Publicado: (2009)